Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Cancer drugs harmful to brain cells

John von Radowitz
Thursday 30 November 2006 01:05 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Common cancer drugs may be more harmful to the brain than the tumour cells they are meant to destroy.

Laboratory tests have shown that dose levels typically used when treating patients killed 70-100 per cent of neural cells but just 40-80 per cent of cancer cells. Several types of healthy brain cell continued to die for at least six weeks after exposure.

The findings, published in the Journal of Biology, may help explain the little understood cancer therapy side effect of "chemo brain".

Patients can suffer symptoms ranging from memory loss to seizures, loss of vision and even dementia. Until recently, these problems were often blamed on a patient's mental state.

However, a growing body of evidence is now leading doctors to accept the reality of "chemo brain".

A study this year suggested that more than 82 per cent of cancer patients may suffer some form of mental impairment. While scientists have suspected that chemotherapy could have an impact on the central nervous system, it was not clear how this might occur.

Mark Noble, from the University of Rochester Medical Centre in New York, who led the research, said: "This is the first study that puts 'chemo brain' on a sound scientific footing, in terms of neurobiology and cellular biology."

The brain is populated with several types of cells that produce or repair normally functioning neurons. These are classified as dividing stem cells, dividing intermediate cells, precursors and progenitors, and non-dividing mature cells. Dr Noble's team exposed healthy brain cells as well as cancer cells to three chemotherapy drugs, carmustine, cisplatin and cytosine arabinoside, used to treat a wide range of diseases, including breast cancer, leukaemia and brain tumours.Tests showed that the drugs were toxic to all the different cell types even at very low concentrations.

The research points to several strategies for making cancer treatments safer, such as applying protective agents and screening to see what cell populations are most at risk.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in